HPV16/18 vaccination to prevent cervical
β
Veerle M.H. CoupΓ©; Joost van Ginkel; Hester E. de Melker; Peter J.F. Snijders; C
π
Article
π
2009
π
John Wiley and Sons
π
French
β 259 KB
## Abstract We evaluated the costβeffectiveness of HPV16/18 vaccination for girls aged 12 years in The Netherlands in addition to cervical cancer screening. For this purpose, we developed a simulation model that describes the relation between each of the highβrisk human papillomavirus (hrHPV) types